Hims & Hers Health, Inc. has grown revenue 54% a year over three years and 67% a year over five. Revenue growth, 3-year annual rate: +54% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +67%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

HIMSHims & Hers Health, Inc.

Healthcare

$30.88-47% 1Y

$30.88

$14.5252 weeks$62.76

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +28% year on year, but operating margin narrowing (−11.6 points).

1 good, 1 to watch, 1 without data

Revenue trend+28% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +67% a year.

Margin direction−11.6 points operating

Trailing-twelve-month operating margin, -5.6% now against 6.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearstop 1% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is HIMS growing?

Hims & Hers Health, Inc. has grown revenue 54% a year over three years and 67% a year over five.

+54%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +67%
Revenue growth, 5-year rate · +54% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›